Retractable Technologies (NYSE:RVP) Stock Price Up 1.9% – What’s Next?

Retractable Technologies, Inc. (NYSE:RVP) shares were up 1.9% on Thursday . The stock traded as high as $0.71 and last traded at $0.69. Approximately 45,700 shares traded hands during trading, a decline of 34% from the average daily volume of 69,094 shares. The stock had previously closed at $0.68.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen started coverage on shares of Retractable Technologies in a report on Thursday, May 22nd. They set a “hold” rating for the company.

Retractable Technologies Price Performance

The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01. The firm’s fifty day moving average price is $0.70 and its two-hundred day moving average price is $0.72. The stock has a market capitalization of $20.71 million, a PE ratio of -1.28 and a beta of 1.39.

Insider Buying and Selling at Retractable Technologies

In other Retractable Technologies news, CEO Thomas J. Shaw bought 86,014 shares of Retractable Technologies stock in a transaction on Thursday, May 15th. The stock was acquired at an average cost of $0.75 per share, with a total value of $64,510.50. Following the completion of the acquisition, the chief executive officer now owns 15,376,794 shares in the company, valued at approximately $11,532,595.50. This represents a 0.56% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Over the last ninety days, insiders acquired 233,962 shares of company stock valued at $168,968. Insiders own 57.10% of the company’s stock.

Institutional Trading of Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. Wealthfront Advisers LLC bought a new stake in shares of Retractable Technologies, Inc. (NYSE:RVP) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 2,533,952 shares of the company’s stock, valued at approximately $1,748,000. Wealthfront Advisers LLC owned about 8.46% of Retractable Technologies at the end of the most recent quarter. 7.58% of the stock is owned by institutional investors and hedge funds.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.